Cargando…
A descriptive follow-up interview study assessing patient-centred outcomes: Salford Lung Study in Asthma (SLS Asthma)
The Salford Lung Study in Asthma (SLS Asthma) was a multicentre, randomised, controlled, open-label trial that assessed initiating once-daily, single-inhaler fluticasone furoate/vilanterol (FF/VI) 100 μg/25 μg or 200 μg/25 μg versus continuing usual care. A subgroup (n = 400) from SLS Asthma was enr...
Autores principales: | Doward, Lynda, Svedsater, Henrik, Whalley, Diane, Crawford, Rebecca, Leather, David, Lay-Flurrie, James, Bosanquet, Nick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6695403/ https://www.ncbi.nlm.nih.gov/pubmed/31417102 http://dx.doi.org/10.1038/s41533-019-0142-x |
Ejemplares similares
-
Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD): follow-up interviews on patient-centred outcomes
por: Doward, Lynda, et al.
Publicado: (2017) -
Follow-up interviews from The Salford Lung Study (COPD) and analyses per treatment and exacerbations
por: Whalley, Diane, et al.
Publicado: (2019) -
Impact of socioeconomic status on participation and outcomes in the Salford Lung Studies
por: Jones, Rupert, et al.
Publicado: (2020) -
Cost–consequence analysis of fluticasone furoate/vilanterol for asthma management in Spain: an analysis based on the Salford Lung Study in asthma
por: Vallejo-Aparicio, Laura Amanda, et al.
Publicado: (2019) -
Linkage of primary care prescribing records and pharmacy dispensing Records in the Salford Lung Study: application in asthma
por: Tibble, Holly, et al.
Publicado: (2020)